Thu, Oct 17 3:54am


ARNA $49.31 0.41 (0.84%)
Arena Pharmaceuticals Inc
NASDAQ: ARNA $3 Billion Mid-Cap. Biotech & Pharma industry. 5 Year Return 18%. 1 Year Return 22%. 2019 YTD Return 23%. Earnings in 20 days on Wed, Nov 6. (Use the Earnings tab below to add this date to your calendar.)

ARNA Profile

Market Cap 3 Billion
ARNA Description

Arena Pharmaceuticals is a biotechnology company targeting G-protein-coupled receptors. The company has one internally discovered drug, lorcaserin, which has been approved and is marketed in the U.S. and South Korea to target weight management. It is commercialized under the brand name Belviq. The company is collaborating with Eisai to market Belviq in other countries. It has a presence in Europe through its Swiss subsidiary, Arena GmbH. The company's pipeline contains drugs targeting autoimmune diseases, vascular diseases, thrombotic diseases, dementia-associated psychosis, nervous system issues, and pain.

Visit Website

ARNA Earnings

EPS -1.24 P/E Ratio 0.00
Previous Wed, Aug 7, 2019
Latest Wed, Nov 6, 2019 (In 20 days)

ARNA Dividend

Yield --
Ex-Date --
Pay Date --
History --

ARNA Charts

1 Year
Nov 14, 2018
Aug 1, 2019

Symbol Price Day Ξ” YTD Ξ”
ARNA $49.31 0.84% 22.60%


Symbol Surfing

How can we make Symbol Surfing better?

©2019 Symbol Surfing All Rights Reserved.

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Cookies Policy | Terms Of Service | Privacy Policy